ADMINISTRATIVE COMPOSITIONS

AR135245A1Pending Publication Date: 2026-08-05AERA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ARP20250100371
Authority / Receiving Office
AR · AR
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-27
Filing Date
2025-02-12
Publication Date
2026-08-05
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.

Claims

A compound of formula (A-II). A compound of formula (BI). A compound of formula (CI). A lipid nanoparticle (LNP) comprising a lipid mixture for the targeted delivery of a nucleic acid to an immune cell, wherein the lipid mixture comprises: (a) a lipid-immune cell targeting group conjugate comprising the compound of formula (II): [Lipid] – [optional connector] – [immune cell targeting group]; and (b) an ionizable cationic lipid comprising any of the compounds of claims 1 to 42, wherein the LNP further comprises a nucleic acid disposed thereon.